Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

HOLICEK, P.; TRUXOVA, I.; RAKOVA, J.; SALEK, C.; HENSLER, M.; KOVAR, M.; REINIS, M.; MIKYSKOVA, R.; PASULKA, J.; VOSAHLIKOVA, S.; REMESOVA, H.; ET AL. Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell death and disease. 2023, vol. 14, no. 3, art. no. 209. ISSN 2041-4889. SJR: 2.188, rok: 2022; Cite Score: 14.300, rok: 2022; IF: 9.000, rok: 2022.